MediWound (MDWD) Other Non-Current Liabilities (2016 - 2025)
MediWound (MDWD) recorded quarterly Other Non-Current Liabilities of $12.7 million in Q4 2025, down 2.47% quarter-over-quarter from $13.0 million in Q3 2025, and down 25.94% on a YoY basis from $17.1 million in Q4 2024.
MediWound (MDWD) Other Non-Current Liabilities (2016 - 2025) Analysis & Trends
MediWound's Other Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $12.7 million for Q4 2025.
- In Q4 2025, Other Non-Current Liabilities fell 25.94% year-over-year to $12.7 million; the TTM figure through Dec 2025 stood at $12.7 million (down 25.94% YoY), while the FY2025 annual figure was $12.7 million, down 25.94% from the prior year.
- Other Non-Current Liabilities was $12.7 million for Q4 2025 at MediWound, down from $13.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $19.1 million in Q3 2024 to a low of $2.3 million in Q4 2023.
- Historically, Other Non-Current Liabilities has averaged $10.5 million across 5 years, with a median of $12.7 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities tumbled 85.54% in 2023, then surged 657.62% in 2024.
- A 5-year view of Other Non-Current Liabilities shows it stood at $3.9 million in 2021, then jumped by 297.91% to $15.6 million in 2022, then sank by 85.54% to $2.3 million in 2023, then soared by 657.62% to $17.1 million in 2024, then slipped by 25.94% to $12.7 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $12.7 million (Q4 2025), $13.0 million (Q3 2025), and $19.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.66 Mn |
| Sep 30, 2025 | 12.98 Mn |
| Jun 30, 2025 | 18.99 Mn |
| Mar 31, 2025 | 12.82 Mn |
| Dec 31, 2024 | 17.09 Mn |
| Sep 30, 2024 | 19.06 Mn |
| Jun 30, 2024 | 14.90 Mn |
| Mar 31, 2024 | 13.07 Mn |
| Dec 31, 2023 | 2.26 Mn |
| Sep 30, 2023 | 8.90 Mn |
| Jun 30, 2023 | 9.68 Mn |
| Mar 31, 2023 | 14.67 Mn |
| Dec 31, 2022 | 15.61 Mn |
| Sep 30, 2022 | 5.09 Mn |
| Mar 31, 2022 | 3.64 Mn |
| Dec 31, 2021 | 3.92 Mn |
| Sep 30, 2021 | 4.20 Mn |
| Jun 30, 2021 | 4.47 Mn |
| Mar 31, 2021 | 4.73 Mn |
| Dec 31, 2020 | 5.00 Mn |